Current through Register Vol. XLI, No. 50, December 13, 2024
Section 69-7-42 - Controlled Substances Monitoring Program Database42.1. Each opioid treatment program shall comply with policies and procedures developed by the designated state oversight agency and the West Virginia Board of Pharmacy to allow physicians treating patients through an opioid treatment program access to the Controlled Substances Monitoring Program database maintained by the West Virginia Board of Pharmacy.42.2. Program physicians shall access the database:42.2.a. At the patient's intake;42.2.b. Before the administration of methadone or other treatment in an opioid treatment program;42.2.c. After the initial thirty days of treatment;42.2.d. Prior to any take-home medication being granted;42.2.e. After any positive drug test; and42.2.f. At each ninety-day treatment review.42.3. The physician shall access the Controlled Substances Monitoring Program database in order to ensure that the patient is not seeking prescription medication from multiple sources. The results obtained from the database shall be maintained with the patient records.